AI-generated summary
This systematic review compared pulsed dye laser with ablative fractional lasers (CO2 and Erbium-YAG) for hypertrophic scars, using clinical trials searched up to December 2022. The authors report no significant difference between the two approaches, both showing significant improvement, and that combined treatment may give better results with no severe adverse reactions noted. They also state that more high-quality trials are needed.
- Who or what was studied
- Patients with hypertrophic scars, as included in clinical trials identified by the review
- Limits stated in the abstract
- The authors state that more high-quality trials are needed to fully confirm the effectiveness of laser therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.